Edition:
United States

Shire PLC (SHPG.OQ)

SHPG.OQ on NASDAQ Stock Exchange Global Select Market

149.41USD
12 Dec 2017
Change (% chg)

-- (--)
Prev Close
$149.41
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
365,086
52-wk High
$192.15
52-wk Low
$137.20

Chart for

About

Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. The Company's segment is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. It focuses its development resources on projects in various therapeutic areas... (more)

Overall

Beta: 1.61
Market Cap(Mil.): $45,619.23
Shares Outstanding(Mil.): 303.19
Dividend: 0.15
Yield (%): 0.62

Financials

  Industry Sector
P/E (TTM): -- 31.96 15.25
EPS (TTM): -- -- --
ROI: -- 15.07 33.27
ROE: -- 16.58 16.35

BRIEF-Shire Says New Formulation Of Oncaspar Receives Marketing Authorization In Europe

* SHIRE PLC SAYS NEW FORMULATION OF ONCASPAR RECEIVES MARKETING AUTHORIZATION IN EUROPE FOR PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA

2:27am EST

BRIEF-Shire Plc Appoints ‍John Miller As Interim CFO

* SHIRE PLC SAYS ‍JOHN MILLER TO SERVE AS INTERIM CFO WITH EFFECT FROM JAN 1, 2018 UNTIL THOMAS DITTRICH COMMENCES HIS EMPLOYMENT WITH CO - SEC FILING​

Dec 08 2017

Whitbread jumps after hedge fund Sachem Head declares stake

LONDON Whitbread shares jumped more than 7 percent on Wednesday after U.S.-based hedge fund Sachem Head Capital Management declared a 3.4 percent stake in the British hotel and coffee chain operator.

Dec 07 2017

Shire in deal to develop a new way to administer hemophilia drug

Shire Plc said on Tuesday it had partnered with a California-based company to develop a new way to administer a drug to treat hemophilia A.

Dec 05 2017

Shire in deal to develop a new way to administer hemophilia drug

Dec 5 Shire Plc said on Tuesday it had partnered with a California-based company to develop a new way to administer a drug to treat hemophilia A.

Dec 05 2017

BRIEF-Shire And Rani Therapeutics enter into collaboration to evaluate use of the Rani Pill technology

* SHIRE AND RANI THERAPEUTICS ENTER INTO COLLABORATION TO EVALUATE USE OF THE RANI PILL(TM) TECHNOLOGY FOR THE ORAL DELIVERY OF FACTOR THERAPY

Dec 05 2017

UPDATE 1-Britain's FTSE recoups early losses as cyclicals recover

* Mediclinic, Spire shares fall after takeover talks fall through

Nov 20 2017

UPDATE 4-Roche haemophilia drug wins FDA nod, with a warning

* Shares in rival Shire climb 6 pct (Adds projected price of drug, company comment)

Nov 16 2017

BRIEF-Omega Advisors dissolves share stake in Carrizo Oil & Gas, ups in Shire PLC

* Omega Advisors Inc dissolves share stake in Carrizo Oil & Gas Inc - SEC Filing‍​

Nov 14 2017

BRIEF-Third Point takes share stake in Macerich, dissolves share stake in Humana

* Third Point LLC dissolves Class A share stake in Charter Communications Inc - SEC filing

Nov 09 2017

Earnings vs. Estimates